Literature DB >> 23916336

Three Leishmania/L. species--L. infantum, L. major, L. tropica--as causative agents of mucosal leishmaniasis in Iran.

Sadegh Shirian1, Ahmad Oryan, Gholam Reza Hatam, Yahya Daneshbod.   

Abstract

Cases of human oro-mucosal leishmaniasis are mainly reported in areas where Leishmania (Viannia) braziliensis perpetuates and the damages are mainly located at the cartilaginous nasal septum and frontal portions of the nasal fossa. In Iran, an area free of any L.(V) braziliensis, three Leishmania species are known to perpetuate through distinct (i) blood-feeding sand flies and (ii) rodents or (iii) canidae. Thus while establishing the diagnosis of any human oro-mucosal lesions, three Leishmania species - L. infantum, L. major, and L. tropica - must be considered as potential etiological agents of these damages. With these objectives in mind, features such as localization, extent, severity of oro-mucosal lesions, and duration of symptoms at the time of diagnosis were recorded from 11 patients with respect to the presence or absence of cutaneous lesions in other body parts. The biopsy samples were collected from the oro-mucosal and cutaneous lesions and were processed for further identification of the Leishmania species. The lesions ranged from mucosal nodules without ulceration, nodules with erosion, and shallow to deep ulcerations. Leishmania major was isolated from six (55%) cases showing lesions or scars. The scars were restricted to upper and lower extremities. For the other five patients who did not display any signs of former or active cutaneous leishmaniasis, L. major, L. tropica, and L. infantum were isolated from their lesions. In conclusion L. major, L. infantum, and L. tropica, regardless of common tropism, can be seen in mucosal tissues. However, L. major was the predominant species detected from the lesions in the nasal, gingival, and hard and soft palates, and L. tropica was isolated from the gingival and lower lip lesions. Leishmania infantum was isolated from two severe cases of deep mucosal damage displayed by the epiglottis, cricoarytenoid muscle, and laryngeal mucosa. One important finding was the association of L. major with active or scarred skin lesions.

Entities:  

Mesh:

Year:  2013        PMID: 23916336      PMCID: PMC4001456          DOI: 10.1179/2047773213Y.0000000098

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  37 in total

1.  A rare case of oral leishmaniasis.

Authors:  Philip A Van Damme; Monique Keuter; Sander Van Assen; Peter C M DeWilde; Pieter J A Beckers
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

2.  Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America.

Authors:  Sukhbir Ahluwalia; Stephen D Lawn; Jeevendra Kanagalingam; Henry Grant; Diana N J Lockwood
Journal:  BMJ       Date:  2004-10-09

3.  Mucocutaneous leishmaniasis due to Leishmania (Leishmania) infantum: biochemical characterization.

Authors:  J Alvar; J A Ballesteros; R Soler; A Benito; G J van Eys; G J Schoone; B Cabrer
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

4.  Isolation of Leishmania guyanensis from lesions of the nasal mucosa.

Authors:  R D Naiff; S Talhari; T V Barrett
Journal:  Mem Inst Oswaldo Cruz       Date:  1988 Oct-Dec       Impact factor: 2.743

5.  Eustachian tube blockage with consequent middle ear infection in mucosal leishmaniasis.

Authors:  H A Lessa; E M Carvalho; P D Marsden
Journal:  Rev Soc Bras Med Trop       Date:  1994 Apr-Jun       Impact factor: 1.581

6.  Detection of Leishmania infantum kinetoplast DNA in laryngeal tissue from an immunocompetent patient.

Authors:  Francesca Guddo; Elena Gallo; Enrico Cillari; Anton Maria La Rocca; Piero Moceo; Kevin Leslie; Thomas Colby; Aroldo G Rizzo
Journal:  Hum Pathol       Date:  2005-09-06       Impact factor: 3.466

7.  [Mucosal localization of leishmaniasis in Tunisia: 5 cases].

Authors:  M Kharfi; B Fazaa; E Chaker; M R Kamoun
Journal:  Ann Dermatol Venereol       Date:  2003-01       Impact factor: 0.777

Review 8.  Leishmaniasis: current situation and new perspectives.

Authors:  P Desjeux
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268

9.  Identification of Leishmania from mucosal leishmaniasis by recombinant DNA probes.

Authors:  H W Ghalib; E A Eltoum; C C Kroon; A M el Hassan
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Mar-Apr       Impact factor: 2.184

10.  Leishmaniasis in Germany.

Authors:  Gundel Harms; Gabriele Schönian; Hermann Feldmeier
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more
  17 in total

1.  Leishmanicidal activity of α-bisabolol from Tunisian chamomile essential oil.

Authors:  Soumaya Hajaji; Ines Sifaoui; Atteneri López-Arencibia; María Reyes-Batlle; Ignacio A Jiménez; Isabel L Bazzocchi; Basilio Valladares; Hafidh Akkari; Jacob Lorenzo-Morales; José E Piñero
Journal:  Parasitol Res       Date:  2018-06-28       Impact factor: 2.289

2.  Progressive Perforation of the Nasal Septum Due to Leishmania major: A Case of Mucosal Leishmaniasis in a Traveler.

Authors:  Nicole Harrison; Julia Walochnik; Reinhard Ramsebner; Luzia Veletzky; Heimo Lagler; Michael Ramharter
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 3.  Plant-derived compounds in treatment of leishmaniasis.

Authors:  A Oryan
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

4.  [Generalized old world leishmaniasis: first Moroccan case in an immunocompetent adult?]

Authors:  Soumiya Chiheb; Zineb Tazi Saoud; Imane El Idrissi Saik; Dounia Darif; Fouzia Hali; Fatima Zahra El Fatoiki; Hayat Skali Dahbi; Ayyoub Kihel; Ikram Hammi; Maha Soussi Abdellaoui; Myriam Riyad
Journal:  Med Trop Sante Int       Date:  2021-11-05

Review 5.  Lip leishmaniasis: a case series with molecular identification and literature review.

Authors:  Iraj Mohammadpour; Mohammad Hossein Motazedian; Farhad Handjani; Gholam Reza Hatam
Journal:  BMC Infect Dis       Date:  2017-01-25       Impact factor: 3.090

6.  Clinical Features of Anthroponotic Cutaneous Leishmaniasis in a Major Focus, Southeastern Iran, 1994-2014.

Authors:  Ahmad Khosravi; Iraj Sharifi; Alireza Fekri; Alireza Kermanizadeh; Mehdi Bamorovat; Mahshid Mostafavi; Mohammad Reza Aflatoonian; Alireza Keyhani
Journal:  Iran J Parasitol       Date:  2017 Oct-Dec       Impact factor: 1.012

7.  A nanoemulsion-based nanogel of Citrus limon essential oil with leishmanicidal activity against Leishmania tropica and Leishmania major.

Authors:  Elham Zarenezhad; Mahmoud Agholi; Ali Ghanbariasad; Ali Ranjbar; Mahmoud Osanloo
Journal:  J Parasit Dis       Date:  2020-11-19

8.  Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report.

Authors:  Hossein Mortazavi; Mehdi Mohebali; Yasaman Taslimi; Pardis Sadeghipour; Mahsa Ansari; Kambiz Kamyab; Marjan Talebi; Ali Khamesipour
Journal:  Iran J Parasitol       Date:  2015 Apr-Jun       Impact factor: 1.012

9.  Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials.

Authors:  Liliana López-Carvajal; Jaiberth Antonio Cardona-Arias; María Isabel Zapata-Cardona; Vanesa Sánchez-Giraldo; Iván Darío Vélez
Journal:  BMC Infect Dis       Date:  2016-07-26       Impact factor: 3.090

10.  Control of Cutaneous Leishmaniasis Using Geographic Information Systems from 2010 to 2014 in Khuzestan Province, Iran.

Authors:  Mojdeh Ostad; Sadegh Shirian; Fatemeh Pishro; Tahereh Abbasi; Armin Ai; Farideh Azimi
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.